We are live on ! Find out more
TRCT

Tower Research Capital (TRC) Portfolio holdings

AUM $3.85B
1-Year Est. Return 32.11%
This Fund
S&P 500
This Quarter Est. Return
+26.23%
1 Year Est. Return
+32.11%
3 Year Est. Return
+93.86%
5 Year Est. Return
+112.79%
10 Year Est. Return
+380.9%
AUM
$2.44B
AUM Growth
+$792M
Cap. Flow
+$442M
Cap. Flow %
18.15%
Top 10 Hldgs %
14.39%
Holding
5,222
New
2,059
Increased
1,821
Reduced
839
Closed
374

Sector Composition

Rank Sector Weight
1 Technology 12.14%
2 Healthcare 9.57%
3 Financials 8.79%
4 Industrials 7.76%
5 Consumer Discretionary 7.68%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
UROV
4251
DELISTED
Urovant Sciences Ltd.
UROV
$6K ﹤0.01%
+649
New +$6.22K
CZZ
4252
DELISTED
Cosan Limited
CZZ
$6K ﹤0.01%
+420
New +$5.5K
FNJN
4253
DELISTED
Finjan Holdings, Inc.
FNJN
$6K ﹤0.01%
+3,804
New +$5.03K
PACD
4254
DELISTED
Pacific Drilling S.A. Common Shares
PACD
$6K ﹤0.01%
12,538
-17,072
-58% -$8.82K
GRA
4255
DELISTED
W.R. Grace & Co.
GRA
$6K ﹤0.01%
117
-1,746
-94% -$82.7K
ADV icon
4256
Advantage Solutions
ADV
$363M
$5K ﹤0.01%
+19
New +$5.09K
GOLD
4257
Gold.com Inc
GOLD
$1.26B
$5K ﹤0.01%
480
-3,224
-87% -$25.5K
AQST icon
4258
Aquestive Therapeutics
AQST
$558M
$5K ﹤0.01%
983
-20,639
-95% -$95K
ARKO icon
4259
ARKO Corp
ARKO
$543M
$5K ﹤0.01%
+502
New +$5.04K
AWRE icon
4260
Aware
AWRE
$27.7M
$5K ﹤0.01%
+1,422
New +$4.3K
AYTU icon
4261
AYTU BioPharma
AYTU
$25.4M
$5K ﹤0.01%
+17
New +$5.15K
BRID icon
4262
Bridgford Foods
BRID
$59.3M
$5K ﹤0.01%
311
-1,258
-80% -$21.8K
CEF icon
4263
Sprott Physical Gold and Silver Trust
CEF
$8.18B
$5K ﹤0.01%
314
+200
+175% +$3.18K
CRVS icon
4264
Corvus Pharmaceuticals
CRVS
$1.14B
$5K ﹤0.01%
1,854
+1,654
+827% +$4.89K
CX icon
4265
Cemex
CX
$16.4B
$5K ﹤0.01%
1,746
-6,065
-78% -$14.2K
DBEF icon
4266
Xtrackers MSCI EAFE Hedged Equity ETF
DBEF
$9.39B
$5K ﹤0.01%
+158
New +$4.58K
EMQQ icon
4267
EMQQ The Emerging Markets Internet & Ecommerce ETF
EMQQ
$275M
$5K ﹤0.01%
106
-1,805
-94% -$69.9K
FHB icon
4268
First Hawaiian
FHB
$3.3B
$5K ﹤0.01%
+284
New +$4.77K
GAU
4269
Galiano Gold
GAU
$520M
$5K ﹤0.01%
3,548
-2,674
-43% -$2.99K
STRR
4270
Star Equity Holdings
STRR
$41.9M
$5K ﹤0.01%
539
+343
+175% +$3.1K
HYMC icon
4271
Hycroft Mining Holding Corp
HYMC
$2.51B
$5K ﹤0.01%
56
-27
-33% -$2.73K
HYS icon
4272
PIMCO 0-5 Year High Yield Corporate Bond Index Exchange-Traded Fund
HYS
$1.77B
$5K ﹤0.01%
50
IBIO icon
4273
iBio
IBIO
$70M
$5K ﹤0.01%
+5
New +$3.27K
IPAY icon
4274
Amplify Mobile Payments ETF
IPAY
$182M
$5K ﹤0.01%
+100
New +$4.49K
IUSV icon
4275
iShares Core S&P US Value ETF
IUSV
$27.8B
$5K ﹤0.01%
+100
New +$5.11K

Similar funds

Tower Research Capital (TRC)'s Q2 2020 Portfolio in Review

As of Q2 2020, Tower Research Capital (TRC) held 5,222 positions worth $2.44B, up 48% from $1.64B the previous quarter. Its ten largest holdings account for 14% of the portfolio.

Tower Research Capital (TRC) deployed $442M of net new capital in Q2 2020, opening 2,059 new positions and adding to 1,821 existing holdings. Its largest new stake was Apple: 428,252 shares worth $39.1M.

By sector, the portfolio is most concentrated in Technology at 12% of assets, up from 3.1% a quarter earlier, followed by Healthcare and Financials.

On the sell side, the largest reduction was State Street SPDR S&P 500 ETF Trust, an estimated $342M trimmed.

  • Tower Research Capital (TRC)'s largest Q2 2020 buy was Apple: 428,252 shares worth $39.1M.
  • Tower Research Capital (TRC) added most to iPath Series B S&P 500 VIX Short-Term Futures ETN in Q2 2020, an estimated $55.3M increase.
  • Tower Research Capital (TRC)'s biggest Q2 2020 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $342M.
  • Tower Research Capital (TRC) fully exited First Trust Technology AlphaDEX Fund in Q2 2020, selling an estimated $2.52M.
  • Tower Research Capital (TRC)'s ten largest holdings make up 14% of its $2.44B portfolio in Q2 2020.
  • Tower Research Capital (TRC) opened 2,059 new positions and closed 374 in Q2 2020.
  • Tower Research Capital (TRC)'s portfolio value rose 48% quarter-over-quarter to $2.44B.

Based on Tower Research Capital (TRC)'s 13F filing for Q2 2020, filed 13 Aug 2020.